Top Markets
Coin of the day
Neovacs S.A. Neovacs S.A.

Neovacs S.A.

ALNEV
Hisse Senetlerindeki Sıralama #21228
Neovacs S.A., a biotechnology company, focuses on the development of... Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Hisse Fiyatı
$0.00047446
Piyasa Değeri
$82.80
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-98.16%
Ülke
FR
Ticaret Neovacs S.A. (ALNEV)

Kategori

Neovacs S.A. (ALNEV) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.00 - 2026-04-01

Gün sonu en düşük fiyat: $55.15K - 2010-04-01
Neovacs S.A. için hisse fiyatı geçmişi: 2010 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 0.00%
2025 -99.78%
2024 592,903.23%
2023 -96.32%
2022 -99.92%
2021 -98.03%
2020 -37.62%
2019 -71.75%
2018 -62.61%
2017 -24.49%
2016 -11.42%
2015 -67.56%
2014 9.35%
2013 -13.08%
2012 -30.76%
2011 40.12%
2010 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$40.81 -35.10%
DK
$441.70 -9.09%
US
$753.93 37.26%
US
$309.47 96.82%
BE
$840.87 43.10%
NL